Phibro Animal Health | PAHC - Net Income


Phibro Animal Health reported $27.46M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Align Technology USD 112.77M 22.99M Mar/2026
ANI Pharmaceuticals USD 29.49M 2.86M Mar/2026
Assertio Holdings USD -2.92M 753K Sep/2024
Aurora Cannabis CAD 1.82M 53.29M Dec/2025
Bristol-Myers Squibb USD 2.68B 1.59B Mar/2026
Canopy Growth CAD -62.63M 60.99M Dec/2025
Corcept Therapeutics USD -31.76M 56.05M Mar/2026
Eli Lilly USD 7.4B 760M Mar/2026
Henry Schein USD 107M 6M Mar/2026
Idexx Laboratories USD 278.45M 30.26M Mar/2026
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Merck USD -4.24B 7.2B Mar/2026
Nektar Therapeutics USD -36.08M 978K Dec/2025
Pacira USD 2.92M 1.28M Mar/2026
Phibro Animal Health USD 27.46M 932K Dec/2025
Prestige Brands USD 46.7M 22.44M Dec/2025
Supernus Pharmaceuticals USD -2.29M 1.81M Mar/2026
Zoetis USD 601M 2M Mar/2026